Kyobo Life CEO may appear in court on next hearing date Lawyer argues Shin Chang-jae needs to be examined given mixed testimonies
Translated by Ryu Ho-joung 공개 2021-11-17 08:07:17
이 기사는 2021년 11월 17일 08:06 thebell 에 표출된 기사입니다.
Shin Chang-jae, chief executive of Kyobo Life Insurance, may appear in court to testify himself in the case against financial investors in the South Korean insurer and individuals from Deloitte Anjin, as some of the witnesses gave different testimonies.At issue in the sixth hearing last Friday was whether Shin was involved in an attempt to alter Deloitte Anjin’s report on the insurance company’s stock valuation in favor of himself.
In 2012, Shin sold part of his shares in Kyobo Life to a consortium consisting of Affinity Equity, IMM Private Equity, Baring Private Equity Asia and Singapore’s GIC. The shareholder agreement included put options that enable the investors to sell their stakes to Shin if the insurer failed to go public by 2015.
Kyobo Life remained as a private company beyond the deadline, prompting the investors to exercise the put options in October 2018 to sell their shares at 409,000 won per share based on the valuation by Deloitte Anjin. Shin refused to buy back the shares, and in January this year, Seoul prosecutors indicted officials from the investor group and individuals from Deloitte Anjin for allegedly mispricing shares subject to the put options.
In the latest hearing, Yun Your-hyun, Kyobo Life’s chief executive, and Cho Dae-gyu, the company’s executive director, appeared as witnesses. A lawyer representing the defendants asked them questions about whether Shin was involved in the overall process of reviewing the valuation report.
Cho testified that he asked an accountant at Daejoo Accounting in 2019 to evaluate the report originally prepared by Deloitte Anjin but did not clearly recall other details.
When asked by the lawyer if he helps Shin with personal matters – given that the agreement subject to the dispute is between Shin and the investors – Cho answered that his action at the time was done on his own, not for Shin.
Following Cho’s testimony, the lawyer for the defendants pointed out that his statement was inconsistent with what Daejoo Accounting’s accountant said. Daejoo Accounting’s accountant earlier testified that he was directly asked by Shin to review Deloitte Anjin’s report.
In a cross-examination of Yun, the lawyer presented a letter sent by Kyobo Life to Deloitte Global as evidence. The insurer said in the letter that it would take legal action unless the US firm took action to have its Korea unit revise the valuation of the company’s shares.
Yun testified that he made the final decision on filing a complaint against Deloitte Anjin with the US Public Company Accounting Oversight Board, adding that he did not discuss the matter with Shin before and after the decision because their roles and authorities are separated.
The lawyer for the defendants argued that Kyobo Life is abusing legal procedures while the company takes no action against Shin, who is responsible for the dispute over the agreement with the investors, and also contended that Shin needs to be examined due to different testimonies from witnesses.
The court accepted the lawyer’s argument on condition that Shin’s attendance in court is not mandatory and the lawyer’s cross-examination will be limited to two hours. (Reporting by Ha-na Suh)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- '재무개선' AJ네트웍스, 조달비용 '확' 낮췄다
- '9년만에 엑시트' 한앤코, 한온시스템 거래구조 살펴보니
- 한국타이어앤테크놀로지, 한온시스템 인수한다
- [수술대 오른 커넥트웨이브]2대주주 지분매입 나선 MBK, 주식교환 카드 꺼냈다
- [이사회 모니터]이재용 에이비프로바이오 대표, 바이오·반도체 신사업 '드라이브'
- 와이투솔루션, 주인 바뀌어도 '신약' 중심엔 美 합작사 '룩사'
- 아이티센, 부산디지털자산거래소 본격 출범
- 아이에스시, AI·데이터센터 수주 증가에 '날개'
- [이사회 모니터]서정학 IBK증권 대표, ESG위원회도 참여 '영향력 확대'
- SW클라우드 '10주년' 폴라리스오피스, “초격차 밸류업”